Chad M Robins's Net Worth

$51.5 Million

Estimate Recalculated Nov 1, 2024 09:19AM EST

Who is Chad M Robins?

Chad M Robins has an estimated net worth of $51.5 Million. This is based on reported shares across multiple companies, which include Adaptive Biotechnologies Corp, CM Life Sciences III Inc., and ARYA Sciences Acquisition Corp II.

SEC CIK

Chad M Robins's CIK is 0001780649

Past Insider Trading and Trends

2020 was Chad M Robins's most active year for acquiring shares with 42 total transactions. Chad M Robins's most active month to acquire stocks was the month of February. 2020 was Chad M Robins's most active year for disposing of shares, totalling 114 transactions. Chad M Robins's most active month to dispose stocks was the month of February. 2020 saw Chad M Robins paying a total of $617,272.15 for 1,089,505 shares, this is the most they've acquired in one year. In 2020 Chad M Robins cashed out on 1,650,495 shares for a total of $32,042,045.09, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Adaptive Biotechnologies Corp (ADPT) Snapshot price: $4.21

CEO and Chairman

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+13.47%
305.94K
$3.43
-$167,007.18
2.58M
Mar 4 - Mar 5
Form 4
+18.51%
354.61K
—
—
2.27M
Mar 6
Form 4
-3.09%
-59.26K
$7.97
-$617,982.35
1.92M
Scheduled
Mar 7 - Mar 9
Form 4
+14.50%
242.69K
$12.01
-$53,132.24
1.92M
Mar 4 - Mar 7
Form 4
-2.53%
-43.50K
$38.43
-$1,671,495.54
1.67M
Scheduled
Sep 8 - Sep 10
Form 4
-0.09%
-1.50K
$38.24
-$57,398.24
1.72M
Scheduled
Jul 12
Form 4
-1.72%
-30.00K
$38.47
-$1,153,964.65
1.72M
Scheduled
Jun 15 - Jun 17
Form 4
-0.85%
-15.00K
$41.81
-$627,106.72
1.75M
Scheduled
Apr 6 - Apr 8
Form 4
-0.84%
-15.00K
$42.89
-$643,416.31
1.76M
Scheduled
Mar 17 - Mar 19
Form 4
+4.02%
68.68K
—
—
1.78M
Mar 4
Form 4
-1.72%
-30.00K
$62.31
-$1,869,322.41
1.71M
Scheduled
Feb 8 - Feb 10
Form 4
-1.70%
-30.00K
$59.38
-$1,781,546.25
1.74M
Scheduled
Jan 26 - Jan 28
Form 4
-0.47%
-8.40K
$70.43
-$591,600.00
1.77M
Scheduled
Jan 19
Form 4
—
0
$30.11
-$2,951,463.91
1.78M
Scheduled
Dec 28 - Dec 30
Form 4
—
0
$23.66
-$2,334,915.89
1.78M
Scheduled
Nov 17 - Nov 19
Form 4
—
0
$25.23
-$4,608,564.28
1.78M
Scheduled
Oct 6 - Oct 8
Form 4
—
0
$25.24
-$124,547.00
1.78M
Scheduled
Sep 29 - Oct 1
Form 4
—
0
$23.11
-$2,273,563.60
5.31M
Scheduled
Sep 16 - Sep 18
Form 4
+1.01%
18.01K
$21.78
-$1,172,832.92
1.78M
Scheduled
Aug 10 - Aug 12
Form 4
—
0
$19.04
-$2,021,408.20
1.78M
Scheduled
Jul 29 - Jul 31
Form 4
—
0
$23.09
-$1,508,293.74
1.78M
Scheduled
Jun 22
Form 4
—
0
$22.45
-$3,082,917.20
1.78M
Scheduled
Jun 17 - Jun 19
Form 4
-5.32%
-100.00K
$20.28
-$5,984,924.00
1.78M
Scheduled
May 19 - May 21
Form 4
—
0
$17.97
-$1,587,117.24
1.88M
Scheduled
May 7
Form 4
+0.05%
1K
$14.30
-$1,356,201.00
1.88M
Scheduled
Apr 13 - Apr 15
Form 4
—
0
$11.42
-$369,731.16
1.88M
Scheduled
Mar 19 - Mar 20
Form 4
—
0
$15.94
-$347,277.60
1.88M
Scheduled
Feb 13
Form 4
—
0
$15.78
-$687,438.40
1.88M
Scheduled
Feb 11 - Feb 12
Form 4
—
0
$15.52
-$1,013,576.80
1.88M
Scheduled
Jan 27 - Jan 29
Form 4
+1.08%
20K
$0.33
$6,600.00
1.88M
Oct 23
Form 4
+3.95%
70.68K
—
—
1.86M
Jul 1
Form 3
—
0
—
—
0
No matching records found

CM Life Sciences III Inc. (EQRX) No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3
—
0
—
—
0
No matching records found

ARYA Sciences Acquisition Corp II (CERE) No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3
—
0
—
—
0
No matching records found